ADAPTIVE BIOTECHNOLOGIES CORPORATION Capital Expenditures Incurred but Not yet Paid
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) reported Capital Expenditures Incurred but Not yet Paid of $806.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-04
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $647.00K, a 4876.92% increase year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $159.00K, a 24.64% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was -$159.00K, a 112.76% decline year-over-year.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was $444.00K.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for fiscal 2025 was $509.00K, a 60.08% decline from fiscal 2024.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for fiscal 2024 was $1.27M, a 85.59% increase from fiscal 2023.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for fiscal 2023 was $687.00K, a 60.03% decline from fiscal 2022.
- ADAPTIVE BIOTECHNOLOGIES CORPORATION capital expenditures incurred but not yet paid for fiscal 2022 was $1.72M, a 152.05% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $647.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $806.00K 10-Q · filed 2026-08-04 | $647.00K derived: sum of 3 quarters · filed 2026-08-04 | $1.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $159.00K 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $444.00K derived: sum of 3 quarters · filed 2026-05-05 | $457.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $285.00K derived: sum of 2 quarters · filed 2026-02-26 | $298.00K derived: sum of 3 quarters · filed 2026-08-04 | $509.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $444.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $457.00K derived: sum of 2 quarters · filed 2026-08-04 | $668.00K 10-Q · filed 2025-11-05 | $1.91M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $224.00K 10-Q · filed 2026-08-04 | $1.47M derived: sum of 3 quarters · filed 2026-08-04 | $1.18M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $211.00K 10-Q · filed 2026-05-05 | $1.46M derived: sum of 2 quarters · filed 2026-05-05 | $1.17M derived: sum of 3 quarters · filed 2026-05-05 | $371.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $960.00K derived: sum of 2 quarters · filed 2026-02-26 | $160.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.27M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$286.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$1.09M derived: sum of 2 quarters · filed 2025-11-05 | $29.00K 10-Q · filed 2025-11-05 | -$592.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $315.00K 10-Q · filed 2025-08-05 | -$306.00K derived: sum of 3 quarters · filed 2026-02-26 | -$289.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.11M 10-Q · filed 2025-05-01 | $494.00K derived: sum of 2 quarters · filed 2026-02-26 | $511.00K derived: sum of 3 quarters · filed 2026-02-26 | $151.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$604.00K derived: sum of 2 quarters · filed 2026-02-26 | -$964.00K derived: sum of 3 quarters · filed 2026-02-26 | $687.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$343.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.31M 10-Q · filed 2024-11-07 | $408.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.29M 10-Q · filed 2024-08-01 | $391.00K derived: sum of 3 quarters · filed 2025-03-03 | -$276.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $1.65M 10-Q · filed 2024-05-07 | $751.00K derived: sum of 2 quarters · filed 2025-03-03 | $84.00K derived: sum of 3 quarters · filed 2025-03-03 | $418.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$1.57M derived: sum of 2 quarters · filed 2025-03-03 | -$1.23M derived: sum of 3 quarters · filed 2025-03-03 | $1.72M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$667.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$333.00K derived: sum of 2 quarters · filed 2023-11-09 | $2.62M 10-Q · filed 2023-11-09 | -$4.83M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $3.29M 10-Q · filed 2023-08-02 | -$4.17M derived: sum of 3 quarters · filed 2024-02-29 | -$3.10M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $2.95M 10-Q · filed 2023-05-03 | -$4.50M derived: sum of 2 quarters · filed 2024-02-29 | -$3.43M derived: sum of 3 quarters · filed 2024-02-29 | -$4.06M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$6.38M derived: sum of 2 quarters · filed 2024-02-29 | -$7.02M derived: sum of 3 quarters · filed 2024-02-29 | $682.00K 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $435.00K derived: sum of 2 quarters · filed 2022-11-03 | $8.13M 10-Q · filed 2022-11-03 | $9.23M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $7.07M 10-Q · filed 2022-08-03 | $8.16M derived: sum of 3 quarters · filed 2023-02-14 | $10.01M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | $7.70M 10-Q · filed 2022-05-04 | $8.79M derived: sum of 2 quarters · filed 2023-02-14 | $10.64M derived: sum of 3 quarters · filed 2023-02-14 | $11.75M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $2.94M derived: sum of 2 quarters · filed 2023-02-14 | $4.05M derived: sum of 3 quarters · filed 2023-02-14 | $4.68M 10-K · filed 2023-02-14 |
| 2020-09-30 | $1.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.96M derived: sum of 2 quarters · filed 2021-11-03 | $3.58M 10-Q · filed 2021-11-03 | $3.86M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | $1.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.74M 10-Q · filed 2021-08-04 | $2.01M derived: sum of 3 quarters · filed 2022-02-15 | $1.02M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | $627.00K 10-Q · filed 2021-05-05 | $902.00K derived: sum of 2 quarters · filed 2022-02-15 | -$90.00K derived: sum of 3 quarters · filed 2022-02-15 | $977.00K derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$717.00K derived: sum of 2 quarters · filed 2022-02-15 | $350.00K derived: sum of 3 quarters · filed 2022-02-15 | $773.00K 10-K · filed 2022-02-15 |
| 2019-09-30 | -$992.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $75.00K derived: sum of 2 quarters · filed 2020-11-10 | $498.00K 10-Q · filed 2020-11-10 | $1.13M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.49M 10-Q · filed 2020-08-10 | $2.13M derived: sum of 3 quarters · filed 2021-02-24 | $1.79M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $423.00K 10-Q · filed 2020-05-12 | $1.06M derived: sum of 2 quarters · filed 2021-02-24 | $720.00K derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | $635.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $297.00K derived: sum of 2 quarters · filed 2021-02-24 | $832.00K 10-K · filed 2021-02-24 | |
| 2018-09-30 | -$338.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $197.00K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | $535.00K 10-Q · filed 2019-08-13 | |||
| 2017-12-31 | $41.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |